Literature DB >> 7997018

Short-course cimetidine and survival with colorectal cancer.

W J Adams, D L Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7997018

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Histamine and histamine receptor regulation of gastrointestinal cancers.

Authors:  Lindsey Kennedy; Kyle Hodges; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-10

2.  Repurposing cimetidine for cholangiocarcinoma: Antitumor effects in vitro and in vivo.

Authors:  Paweena Dana; Kulthida Vaeteewoottacharn; Ryusho Kariya; Kouki Matsuda; Sopit Wongkham; Seiji Okada
Journal:  Oncol Lett       Date:  2017-01-02       Impact factor: 2.967

Review 3.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis.

Authors:  Toshiaki Kinouchi; Junichi Sakamoto; Taiji Tsukamoto; Hideyuki Akaza; Yoshinobu Kubota; Seiichiro Ozono; Hiroshi Kanetake; Tetsuo Taguchi; Toshihiko Kotake
Journal:  J Cancer Res Clin Oncol       Date:  2006-04-04       Impact factor: 4.553

Review 5.  Chemoprevention of colorectal cancer.

Authors:  M Langman; P Boyle
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

6.  Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.

Authors:  Cong-Yao Lin; De-Jiao Bai; Hong-Yin Yuan; Kun Wang; Guo-Liang Yang; Ming-Bai Hu; Zhou-Qing Wu; Yan Li
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

7.  Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients.

Authors:  T Kubota; H Fujiwara; Y Ueda; T Itoh; T Yamashita; T Yoshimura; K Okugawa; Y Yamamoto; Y Yano; H Yamagishi
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

8.  Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells.

Authors:  S Matsumoto; Y Imaeda; S Umemoto; K Kobayashi; H Suzuki; T Okamoto
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

9.  Cimetidine in colorectal cancer--are the effects immunological or adhesion-mediated?

Authors:  D Eaton; R E Hawkins
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

Review 10.  Mast Cells: A New Frontier for Cancer Immunotherapy.

Authors:  Jake N Lichterman; Sangeetha M Reddy
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.